Covid-19 vaccine approvals and stock market returns: the case of Chinese stocks

DOI10.1016/J.ECONLET.2022.110466zbMATH Open1493.91119OpenAlexW4220899912MaRDI QIDQ2158358FDOQ2158358

Authors Yi-Bo Gao, Qiying Gu, Da Yang, Ken-Chung Ho 

Publication date 26 July 2022

Published in Economics Letters (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1016/j.econlet.2022.110466

zbMATH Keywords

COVID-19stock market returnsvaccine news

Mathematics Subject Classification ID

Medical epidemiology (92C60) Financial markets (91G15)

Recommendations

• Stay-at-home stocks versus go-outside stocks: the impacts of COVID-19 on the Chinese stock market
• Many hands make light work: evidence from China's anti-epidemic bonds
• COVID-19: what is going on with the stock market in Vietnam
• Kindness is rewarded! The impact of corporate social responsibility on Chinese market reactions to the COVID-19 pandemic
• Developed and emerging stock markets volatility during the global pandemic of coronavirus disease 2019 (COVID-19): dynamic correlation approach

Cites Work

• Kindness is rewarded! The impact of corporate social responsibility on Chinese market reactions to the COVID-19 pandemic

Cited In (5)

• Study on announcement effect of stock repurchase from the perspective of configuration analysis
• The stock performance of green bond issuers during COVID-19 pandemic: the case of China
• Stay-at-home stocks versus go-outside stocks: the impacts of COVID-19 on the Chinese stock market
• Many hands make light work: evidence from China's anti-epidemic bonds
• COVID-19: what is going on with the stock market in Vietnam

This page was built for publication: Covid-19 vaccine approvals and stock market returns: the case of Chinese stocks

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2158358)